Provakcin Plus 100ml
Provakcin Plus was a product that reduced the possible side effects of vaccination. Provakcin was launched in 2014 by its distributor, Apotex.
It was manufactured by the Marabu company. A pharmacological and analytical analysis of the contents of Provakcin Plus ingredients was performed by Prof. RNDr. Jiří Patočka, DrSc, a leading toxicologist.
GIMMEXIN AS A QUALITY SUCCESSOR TO PROVAKCIN PLUS
Provakcin was selling well, but massive investments in research and development resulted in problems with the manufacturer, and production was stopped. The distributor later lost its patent rights. Discussions on the popular Czech server Emimino, for example, made it clear that the product Provakcin Plus had become very popular, and parents missed it on the market for its effectiveness.
The IML company became very interesting in this product and subsequently revived it. It negotiated with the patent rights holder and obtained patent rights for production and distribution for the Czech Republic and Slovakia. The name “Provakcin Plus” is a protected trademark whose owner has not consented to its further use. This is why it is now impossible to refer to it by this name.
IML made improvements to the recipe by replacing cheap sugars with higher quality ones. It also conducted stability and leaching tests to ensure that Gimmexin is a quality successor to Provakcin Plus.
IML has also improved the production process and documented it according to the methodology of Good Manufacturing Practices. It also made use of studies on the individual ingredients and compiled possible areas of effect on the body.
The full list of studies includes 223 studies from reputed servers such as Pubmed, NCBI, etc. This shows that the product will have more extensive effects than just in the area of vaccination.
We believe that Gimmexin will become even more popular than its predecessor.